These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21054933)

  • 1. Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity.
    Pradier A; Passweg J; Villard J; Kindler V
    Cell Transplant; 2011; 20(5):681-91. PubMed ID: 21054933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies.
    Hoogduijn MJ; Roemeling-van Rhijn M; Korevaar SS; Engela AU; Weimar W; Baan CC
    Hum Gene Ther; 2011 Dec; 22(12):1587-91. PubMed ID: 21732766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
    Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
    Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic activation of the cytotoxic phenotype during human NK cell development.
    Meade JL; Wilson EB; Holmes TD; de Wynter EA; Brett P; Straszynski L; Ballard PA; Trapani JA; McDermott MF; Cook GP
    J Immunol; 2009 Jul; 183(2):803-13. PubMed ID: 19570824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
    Chen GH; Wu DP; Sun AN; Yang MZ; Wang Y; Tang XW; Chang HR; Feng YF; Zhu ZL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):526-30. PubMed ID: 19112915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.
    Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
    Transplantation; 2003 Oct; 76(8):1208-13. PubMed ID: 14578755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between human mesenchymal stem cells and natural killer cells.
    Sotiropoulou PA; Perez SA; Gritzapis AD; Baxevanis CN; Papamichail M
    Stem Cells; 2006 Jan; 24(1):74-85. PubMed ID: 16099998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
    Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
    Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of natural killer activity of human bone marrow and blood cells in cultures containing IL-2, IL-7 and IL-12.
    Wong EK; Eaves C; Klingemann HG
    Bone Marrow Transplant; 1996 Jul; 18(1):63-71. PubMed ID: 8831997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R; Nagler A
    Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
    Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
    Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells.
    Petrini I; Pacini S; Petrini M; Fazzi R; Trombi L; Galimberti S
    Eur J Clin Invest; 2009 Sep; 39(9):813-8. PubMed ID: 19522834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
    Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
    Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune protection function of multipotent mesenchymal stromal cells: role of transforming growth factor-β1.
    Zhao ZG; Cao Z; Xu W; Sun L; You Y; Li F; Li QB; Zou P
    Cancer Invest; 2012 Nov; 30(9):646-56. PubMed ID: 23020627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.
    Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F
    J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
    Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
    Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
    Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
    Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.